Literature DB >> 21969163

Lymphadenectomy via a cervical approach for upper mediastinal lymph node recurrence of esophageal cancer: report of a case.

Hiroyuki Tada1, Atsushi Shiozaki, Hitoshi Fujiwara, Daisuke Ichikawa, Kazuma Okamoto, Shuhei Komatsu, Yasutoshi Murayama, Hisashi Ikoma, Yoshiaki Kuriu, Masayoshi Nakanishi, Toshiya Ochiai, Yukihito Kokuba, Teruhisa Sonoyama, Eigo Otsuji.   

Abstract

Although there have been several reports about salvage esophagectomy after definitive chemoradiotherapy (CRT), the effectiveness of lymphadenectomy for lymph node recurrence after CRT has not been fully evaluated. Radiation-induced tissue injury and fibrosis make lymphadenectomy after CRT difficult, therefore the choice of surgical approach should be considered carefully. We performed lymphadenectomy via a cervical approach in a 76-year-old man with upper mediastinal lymph node recurrence. He had previously undergone subtotal esophagectomy for squamous cell carcinoma of the upper thoracic esophagus. At 33 months after the operation, left upper mediastinal lymph node recurrence occurred. After localized CRT with docetaxel plus 60 Gy radiation, the tumor disappeared. However, at 1 year after CRT a lymph node recurrence, measuring 10 mm in size, was found in the same position on a computed tomography (CT) scan and (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) without other recurrences. Lymphadenectomy was performed via a left cervical approach using a Kent retractor to extend the surgical view of the cervicothoracic region. The patient was discharged without complications, and a postoperative CT scan and FDG-PET revealed complete resection of the tumor. In conclusion, our surgical procedure provides a good surgical view, and decreases surgical stress and the incidence of postoperative complications.

Entities:  

Mesh:

Year:  2011        PMID: 21969163     DOI: 10.1007/s00595-010-4521-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study.

Authors:  L R Coia; B D Minsky; B A Berkey; M J John; D Haller; J Landry; T M Pisansky; C G Willett; J P Hoffman; J B Owen; G E Hanks
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Direct-vision retrosternal dissection using the Kent retractor for sternal re-entry.

Authors:  Kenji Kuwaki; Masaru Tsukamoto; Kanshi Komatsu; Junichi Sakata; Satoshi Muraki; Tomio Abe
Journal:  Surg Today       Date:  2004       Impact factor: 2.549

3.  Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.

Authors:  Tsutomu Nakamura; Kazuhiko Hayashi; Masaho Ota; Reiki Eguchi; Hiroko Ide; Ken Takasaki; Norio Mitsuhashi
Journal:  Am J Surg       Date:  2004-09       Impact factor: 2.565

4.  Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.

Authors:  Yuji Ueda; Atsushi Shiozaki; Hirosumi Itoi; Kazuma Okamoto; Hitoshi Fujiwara; Daisuke Ichikawa; Shojiro Kikuchi; Nobuaki Fuji; Tsuyoshi Itoh; Toshiya Ochiai; Shuhei Komatsu; Hisakazu Yamagishi
Journal:  Oncol Rep       Date:  2006-11       Impact factor: 3.906

5.  Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer.

Authors:  M Yano; K Takachi; Y Doki; I Miyashiro; K Kishi; S Noura; H Eguchi; T Yamada; M Ohue; H Ohigashi; Y Sasaki; O Ishikawa; T Matsunaga; S Imaoka
Journal:  Dis Esophagus       Date:  2006       Impact factor: 3.429

6.  Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus.

Authors:  K Sugimachi; K Inokuchi; H Kuwano; H Kai; T Okamura; Y Okudaira
Journal:  Surg Gynecol Obstet       Date:  1983-12

7.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

8.  Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.

Authors:  Atsushi Shiozaki; Hisakazu Yamagishi; Hirosumi Itoi; Hitoshi Fujiwara; Shojiro Kikuchi; Kazuma Okamoto; Daisuke Ichikawa; Nobuaki Fuji; Toshiya Ochiai; Teruhisa Sonoyama; Yuji Ueda
Journal:  Oncol Rep       Date:  2005-04       Impact factor: 3.906

9.  Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.

Authors:  B M Smithers; M Cullinan; J M Thomas; I Martin; A P Barbour; B H Burmeister; J A Harvey; D B Thomson; E T Walpole; D C Gotley
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

10.  Salvage esophagectomy following definitive chemoradiotherapy.

Authors:  Mitsuyo Nishimura; Hiroyuki Daiko; Junji Yoshida; Kanji Nagai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-11
View more
  1 in total

1.  Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy.

Authors:  Masanobu Nakajima; Yasushi Domeki; Hitoshi Satomura; Masakazu Takahashi; Akira Sugawara; Hiroto Muroi; Kinro Sasaki; Satoru Yamaguchi; Tatsuya Miyazaki; Hiroyuki Kuwano; Hiroyuki Kato
Journal:  Int Surg       Date:  2014 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.